Home Ingredients enfinity® Paraxanthine
CognitiveEnergy

enfinity® Paraxanthine

Evidence Level
Moderate
3 Clinical Trials
4 Documented Benefits
3/5 Evidence Score

enfinity® is a branded, pharmaceutical-grade form of paraxanthine, the primary metabolite of caffeine in the human body. After ingesting caffeine, roughly 80% is metabolized to paraxanthine by hepatic CYP1A2, and a growing body of branded research suggests that supplementing paraxanthine directly delivers many of caffeine's cognitive and performance benefits with a different side-effect profile, including potentially less reported jitter, less impact on heart rate, and a shorter half-life. Acute and short-term dose-response trials at 50-200 mg in healthy adults have explored effects on attention, memory, reaction time, and exercise-related cognition, while preclinical and safety toxicology studies support a no-observed-adverse-effect level well above typical human serving sizes. As a newer category, enfinity® is most often used at 100-200 mg in cognitive and pre-workout formulas.

Studied Dose 100-200 mg per serving; 50, 100, and 200 mg evaluated in published dose-response trials.
Active Compound Paraxanthine (1,7-dimethylxanthine), the primary methylxanthine metabolite of caffeine, supplied as 95%+ pure pharmaceutical-grade powder.

Benefits

Supports Cognitive Performance

Acute trials of 100-200 mg paraxanthine have reported improvements in reaction time, attention, and short-term memory in healthy adults compared with placebo, supporting use as a focus and mental-energy ingredient.

Supported by Trial 2, Trial 1

Helps Sustain Attention Under Load

Single-dose work suggests paraxanthine may help support sustained attention on demanding tasks, with effects in the range typically associated with moderate caffeine doses.

Supported by Trial 2, Trial 1

May Support Post-Exercise Cognition

In trained runners, paraxanthine has been compared with caffeine after a 10-km run, with the paraxanthine condition showing favorable effects on prefrontal cortex function and reaction time relative to caffeine and placebo.

Supported by Trial 3, Trial 2

Caffeine Metabolite With a Distinct Profile

As the primary metabolite of caffeine, paraxanthine shares the adenosine-antagonism mechanism that drives focus and arousal, while a shorter half-life and different receptor binding profile may translate to a smoother subjective experience in some users.

Supported by Trial 3

Mechanism of action

1

Adenosine Receptor Antagonism

Paraxanthine competitively blocks adenosine A1 and A2A receptors in the central nervous system, reducing the sleep-promoting and fatigue-signaling effects of adenosine and supporting wakefulness and focus.

2

Dopamine and Catecholamine Signaling

Through A2A receptor blockade, paraxanthine indirectly enhances dopaminergic signaling in regions associated with motivation, attention, and reward — a mechanism shared with caffeine.

3

Lipolysis and Bioenergetic Effects

Like other methylxanthines, paraxanthine increases cAMP and supports lipolysis at higher doses, with potential downstream effects on substrate availability during exercise.

Clinical trials

1
Dose-Response of Paraxanthine on Cognition

Double-blind, placebo-controlled, crossover trial; 50, 100, and 200 mg paraxanthine vs placebo with 7-day daily intake assessments

12 healthy young adults

Acute paraxanthine ingestion was associated with improvements across several cognitive measures, most consistently at the 100-200 mg doses; 7-day daily ingestion was reported to be free of clinically significant side effects.

2
Acute 200 mg Paraxanthine and Cognition

Double-blind, placebo-controlled, crossover trial; single 200 mg paraxanthine vs placebo on cognitive and attentional tasks

13 healthy male and female participants

A single 200 mg dose was associated with improvements in markers of cognitive function and short-term memory and helped sustain attention compared with placebo, with no reported adverse events.

3
Paraxanthine vs Caffeine After Endurance Running

Double-blind, randomized, crossover trial; 200 mg paraxanthine vs 200 mg caffeine vs placebo combinations following a 10-km run

12 trained runners

Paraxanthine was associated with greater improvements in cognitive function after the 10-km run than caffeine; co-ingesting both did not produce additive benefits, suggesting distinct nootropic action.

Side effects and drug interactions

Common Potential side effects

Generally well tolerated in trials at 50-200 mg; mild headache or jitteriness possible at higher doses.
May cause GI upset, especially on an empty stomach.
Stimulant cross-tolerance and sleep disruption are possible if taken late in the day.
Long-term human safety data beyond short trial durations remain limited.

Important Drug interactions

Theoretical additive effects with caffeine and other stimulants — combine cautiously.
CYP1A2 inhibitors and inducers may modify paraxanthine pharmacokinetics.
Discuss use with a clinician if you take antiarrhythmics or stimulant medications.

More Cognitive Ingredients

Cognitive
Vitamin B12
Vitamin B12, also known as cobalamin, is a water-soluble vitamin commonly supplemented as…
Cognitive
Longvida® Optimized Curcumin (Verdure Sciences)
Longvida® is a patented curcumin extract developed by Verdure Sciences using SLCP™ (Solid…
Cognitive
CurQfen® (Curcumin-Fenugreek FenuMat — Akay Bioactives)
CurQfen® is a patented curcumin complex from Curcuma longa rhizomes formulated with FENUMA…
Cognitive
Ashwagandha
Ashwagandha (Withania somnifera) is an adaptogenic herb from Ayurvedic tradition, widely u…

Explore Other Ingredients

Energy
TeaCrine® (Theacrine)
TeaCrine® is Compound Solutions' patented theacrine — a purine alkaloid (1,3,7,9-tetrameth…
Cognitive
Citicoline
Citicoline (CDP-choline) is a naturally-occurring intermediate in phosphatidylcholine bios…
Cognitive
Suntheanine®
Suntheanine® is a patented, 100% pure L-isomer theanine produced via an enzymatic process…

Frequently asked questions about enfinity® Paraxanthine

What is enfinity Paraxanthine?

enfinity® is a branded, pharmaceutical-grade form of paraxanthine, the primary metabolite of caffeine in the human body. After ingesting caffeine, roughly 80% is metabolized to paraxanthine by hepatic CYP1A2, and a growing body of branded research suggests that supplementing paraxanthine directly delivers many of caffe…

What is enfinity Paraxanthine used for?

enfinity Paraxanthine is researched primarily for Cognitive and Energy. Acute trials of 100-200 mg paraxanthine have reported improvements in reaction time, attention, and short-term memory in healthy adults compared with placebo, supporting use as a focus and mental-energy ingredient.

What is the recommended dosage of enfinity Paraxanthine?

The clinically studied dose is 100-200 mg per serving; 50, 100, and 200 mg evaluated in published dose-response trials. Always follow the product label and check with a healthcare provider for personal advice.

Is enfinity Paraxanthine safe, and does it have side effects?

For most healthy adults, enfinity Paraxanthine is well tolerated at studied doses. Reported effects can include: Generally well tolerated in trials at 50-200 mg; mild headache or jitteriness possible at higher doses. May cause GI upset, especially on an empty stomach. It may also interact with some medications. enfinity Paraxanthine is not right for everyone, so check with a healthcare provider first if you are pregnant or breastfeeding, have a medical condition, or take prescription medication.

Does enfinity Paraxanthine interact with any medications?

Possible interactions include: Theoretical additive effects with caffeine and other stimulants — combine cautiously. CYP1A2 inhibitors and inducers may modify paraxanthine pharmacokinetics. If you take prescription medication, check with a pharmacist or doctor before using it.

How strong is the scientific evidence for enfinity Paraxanthine?

NutraSmarts rates the evidence for enfinity Paraxanthine as Moderate (3 out of 5). It is backed by 3 clinical trials and 3 cited references summarized on this page. A higher rating reflects more, larger, and better-designed human studies.

References(3 citations)

Evidence ratings on NutraSmarts are based on the totality of human clinical research, with emphasis on randomized controlled trials, meta-analyses, and systematic reviews. The references below directly support claims made throughout this page.

  1. Xing D, Yoo C, Gonzalez D, et al. Dose-response of paraxanthine on cognitive function: a double blind, placebo controlled, crossover trial. Nutrients. 2021;13(12):4478. doi: 10.3390/nu13124478.PubMedUsed to support: Crossover trial of 50/100/200 mg paraxanthine reporting cognitive improvements (most consistent at 100-200 mg) and tolerability over 7-day daily intake.
  2. Yoo C, Xing D, Gonzalez D, et al. Acute paraxanthine ingestion improves cognition and short-term memory and helps sustain attention in a double-blind, placebo-controlled, crossover trial. Nutrients. 2021;13(11):3980. doi: 10.3390/nu13113980.PubMedUsed to support: Crossover trial of single 200 mg paraxanthine in 13 adults showing improved cognitive function, short-term memory, and sustained attention vs placebo.
  3. Purpura M, Jäger R, Falk M. An assessment of mutagenicity, genotoxicity, acute-, subacute and subchronic oral toxicity of paraxanthine (1,7-dimethylxanthine). Food Chem Toxicol. 2021;158:112579. doi: 10.1016/j.fct.2021.112579.PubMedUsed to support: Comprehensive toxicology battery establishing NOAEL ≥300 mg/kg/day in 90-day subchronic rat study, no genotoxicity or mutagenicity signal.